Compare FIP & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIP | SRZN |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Consumer Electronics/Appliances | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.8M | 276.3M |
| IPO Year | 2021 | 2020 |
| Metric | FIP | SRZN |
|---|---|---|
| Price | $2.85 | $29.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $9.44 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 1.4M | 496.3K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | ★ 4.20% | N/A |
| EPS Growth | ★ 16.91 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $502,520,000.00 | $3,477,000.00 |
| Revenue This Year | $45.32 | $208.89 |
| Revenue Next Year | $21.93 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.59 | N/A |
| 52 Week Low | $2.23 | $11.39 |
| 52 Week High | $6.69 | $37.83 |
| Indicator | FIP | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 58.55 |
| Support Level | $2.59 | $24.16 |
| Resistance Level | $2.89 | $30.19 |
| Average True Range (ATR) | 0.18 | 2.06 |
| MACD | 0.08 | 0.31 |
| Stochastic Oscillator | 78.95 | 72.73 |
FTAI Infrastructure Inc is engaged in five segments; Railroad segment, which includes eight freight railroads and one switching company that provide rail service to certain manufacturing and production facilities; the Jefferson Terminal segment, which consists of a multi-modal crude oil and refined products terminal and other related assets; The Repauno segment, which consists of a deep-water port located along the Delaware River with an underground storage cavern, a multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities; Power and Gas segment, which comprised Long Ridge, a multi-modal terminal located along the Ohio River; and Sustainability and Energy Transition segment, which comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).